These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10672947)

  • 61. Laparoscopic radical nephrectomy for patients with pathologic T3b renal-cell carcinoma: the Johns Hopkins experience.
    Guzzo TJ; Schaeffer EM; McNeil BK; Pollock RA; Pavlovich CP; Allaf ME
    J Endourol; 2009 Jan; 23(1):63-7. PubMed ID: 19119807
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumor enucleation for small renal masses.
    Laryngakis NA; Guzzo TJ
    Curr Opin Urol; 2012 Sep; 22(5):365-71. PubMed ID: 22647650
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein.
    Woldu SL; Barlow LJ; Patel T; Hruby GW; Benson MC; McKiernan JM
    Urology; 2010 Sep; 76(3):639-42. PubMed ID: 20163841
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma.
    Akdogan B; Gudeloglu A; Inci K; Gunay LM; Koni A; Ozen H
    Clin Genitourin Cancer; 2012 Jun; 10(2):121-5. PubMed ID: 22401753
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm].
    Boulière F; Crepel M; Bigot P; Pignot G; Bessede T; de la Taille A; Salomon L; Tostain J; Bellec L; Soulié M; Rischmann P; Bernhard JC; Ferrière JM; Pfister C; Albouy B; Colombel M; Zini L; Villers A; Rigaud J; Bouchot O; Patard JJ
    Prog Urol; 2011 Nov; 21(12):842-50. PubMed ID: 22035910
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contemporary status of open nephron-sparing surgery in renal cell carcinoma.
    Ljungberg B
    Arch Ital Urol Androl; 2009 Jun; 81(2):61-4. PubMed ID: 19760857
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and efficacy of laparoscopic radical nephrectomy with manual specimen morcellation for stage cT1 renal-cell carcinoma.
    Lesani OA; Zhao LC; Han J; Okotie O; Desireddi NV; Johnston WK; Nadler RB
    J Endourol; 2008 Jun; 22(6):1257-9. PubMed ID: 18578659
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
    Belldegrun A; Tsui KH; deKernion JB; Smith RB
    J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
    Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
    BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma.
    Shin S; Han Y; Park H; Chung YS; Ahn H; Kim CS; Cho YP; Kwon TW
    J Vasc Surg; 2013 Oct; 58(4):1021-7. PubMed ID: 23591189
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
    Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
    Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term renal functional outcomes of minimally invasive partial nephrectomy for renal cell carcinoma.
    Mukkamala A; He C; Weizer AZ; Hafez KS; Miller DC; Montgomery JS; Bitzer M; Stuart Wolf J
    Urol Oncol; 2014 Nov; 32(8):1247-51. PubMed ID: 24846342
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [A partial nephrectomy in renal cell carcinoma].
    Masuda F; Suzuki H; Kurauchi H; Mitani H; Kawahara M; Nishida A
    Gan No Rinsho; 1989 Aug; 35(9):1025-9. PubMed ID: 2671430
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Surgical treatment of renal neoplasia: evolving toward a laparoscopic standard of care.
    Bhayani SB; Clayman RV; Sundaram CP; Landman J; Andriole G; Figenshau RS; Bullock A; Brandes S; Shalhav A; McDougall E; Kibel AS
    Urology; 2003 Nov; 62(5):821-6. PubMed ID: 14624901
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Renal cell carcinoma: A 12-year retrospective study of epidemiologic, therapeutic and follow-up data].
    Arnoux V; Long JA; Jund J; Fiard G; Terrier N; Thuillier C; Boillot B; Rambeaud JJ; Descotes JL
    Prog Urol; 2013 Jan; 23(1):15-21. PubMed ID: 23287479
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Renal oncocytoma: a diagnostic and therapeutic dilemma.
    Maatman TJ; Novick AC; Tancinco BF; Vesoulis Z; Levin HS; Montie JE; Montague DK
    J Urol; 1984 Nov; 132(5):878-81. PubMed ID: 6492276
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Two cases of renal cell carcinoma that underwent radical nephrectomy subsequent to complete tumor enucleation].
    Horikawa N; Chihara Y; Hayashi Y; Fujimoto K; Hosokawa Y; Otani T; Ozono S; Hirao Y
    Nihon Hinyokika Gakkai Zasshi; 2001 Nov; 92(7):710-3. PubMed ID: 11766372
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Can partial nephrectomy preserve renal function and modify survival in comparison with radical nephrectomy?
    Medina-Polo J; Romero-Otero J; Rodríguez-Antolín A; Domínguez-Esteban M; Passas-Martínez J; Villacampa-Aubá F; Lora-Pablos D; Gómez De La Cámara A; Díaz-González R
    Scand J Urol Nephrol; 2011 Mar; 45(2):143-50. PubMed ID: 21247272
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer.
    Abdollah F; Arora S; von Landenberg N; Gild P; Sood A; Dalela D; Trinh QD; Menon M; Rogers C
    BJU Int; 2018 Mar; 121(3):345-347. PubMed ID: 28972695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.